We are live on
!
Find out more
DZ Bank Portfolio holdings
AUM
$113B
1-Year Est. Return
36.92%
This Fund
S&P 500
This Quarter
Est. Return
-1.28%
1 Year Est. Return
+36.92%
3 Year Est. Return
+150.91%
5 Year Est. Return
+223.96%
10 Year Est. Return
–
AUM
$70.4B
AUM Growth
+$3.85B
(+5.8%)
Cap. Flow
+$4.62B
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
34.8%
Holding
1,088
New
69
Increased
276
Reduced
305
Closed
107
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$1.1B |
| 2 |
UnitedHealth
UNH
|
+$936M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$755M |
| 4 |
Oracle
ORCL
|
+$638M |
| 5 |
Humana
HUM
|
+$605M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$566M |
| 2 |
Accenture
ACN
|
+$454M |
| 3 |
PPG Industries
PPG
|
+$430M |
| 4 |
Coca-Cola
KO
|
+$421M |
| 5 |
Advanced Micro Devices
AMD
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.89% |
| 2 | Healthcare | 16.66% |
| 3 | Financials | 10.28% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Union Pacific
UNP
$174B
| $102M | 0.14% |
498,729
+303,136
| +155% | +$66M |
|
|
102
Edwards Lifesciences
EW
$49.4B
| $101M | 0.14% |
1,458,617
-7,040,366
| -83% | -$566M |
|
103
Ingersoll Rand
IR
$33.1B
| $98.4M | 0.14% |
1,544,527
-414,504
| -21% | -$27.6M |
|
104
Bristol-Myers Squibb
BMY
$129B
| $96.3M | 0.14% |
1,658,743
+100,824
| +6% | +$6.18M |
|
|
SCHW
105
Charles Schwab
SCHW
$182B
| $95.7M | 0.14% |
1,742,363
-6,059,792
| -78% | -$366M |
|
106
IQVIA
IQV
$40.7B
| $92.5M | 0.13% |
470,192
+281,436
| +149% | +$61.1M |
|
107
D.R. Horton
DHI
$41.2B
| $90.5M | 0.13% |
841,999
+807,742
| +2,358% | +$96.7M |
|
108
TJX Companies
TJX
$179B
| $89.4M | 0.13% |
1,005,852
-55,054
| -5% | -$4.85M |
|
109
Aon
AON
$80.6B
| $88.7M | 0.13% |
273,727
-183,593
| -40% | -$60.7M |
|
110
Rockwell Automation
ROK
$51.1B
| $86.9M | 0.12% |
303,917
-65,504
| -18% | -$20.3M |
|
111
Arista Networks
ANET
$199B
| $86.7M | 0.12% |
1,886,292
-229,536
| -11% | -$10.2M |
|
|
GTLS
112
CALL
DELISTED
Chart Industries
GTLS
| $85.7M | 0.12% |
501,700
+201,700
| +67% | +$33.9M |
|
113
ICICI Bank
IBN
$107B
| $84.9M | 0.12% |
3,672,983
-696,071
| -16% | -$16.4M |
|
114
Starbucks
SBUX
$119B
| $83.4M | 0.12% |
913,671
+74,025
| +9% | +$7.27M |
|
115
Clorox
CLX
$12B
| $80.2M | 0.11% |
612,291
-127,026
| -17% | -$19.3M |
|
116
CALL
Johnson & Johnson
JNJ
$640B
| $78.6M | 0.11% |
+504,000
| New | +$83.2M |
|
117
Cummins
CMI
$83.6B
| $77.6M | 0.11% |
339,769
-26,661
| -7% | -$6.44M |
|
118
Mettler-Toledo International
MTD
$28.1B
| $77.5M | 0.11% |
69,953
-53
| -0.1% | -$64.9K |
|
119
Vertex Pharmaceuticals
VRTX
$123B
| $74.9M | 0.11% |
215,370
+38,677
| +22% | +$13.5M |
|
|
120
CALL
Vertex Pharmaceuticals
VRTX
$123B
| $74.4M | 0.11% |
213,000
| – | – |
|
121
ConocoPhillips
COP
$144B
| $73.1M | 0.1% |
609,861
+409,542
| +204% | +$47.5M |
|
|
GTLS
122
DELISTED
Chart Industries
GTLS
| $72.4M | 0.1% |
428,018
+273,059
| +176% | +$45.9M |
|
123
Abbott
ABT
$188B
| $69.5M | 0.1% |
717,877
+342,810
| +91% | +$36M |
|
124
Coty
COTY
$2.4B
| $68.1M | 0.1% |
6,211,084
+444,919
| +8% | +$5.24M |
|
|
HOLX
125
DELISTED
Hologic
HOLX
| $67.4M | 0.1% |
971,500
+274,242
| +39% | +$20.7M |
|
Similar funds
VAM
DZ Bank's Q3 2023 Portfolio in Review
As of Q3 2023, DZ Bank held 1,088 positions worth $70.4B, up 5.8% from $66.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
DZ Bank deployed $4.62B of net new capital in Q3 2023, opening 69 new positions and adding to 276 existing holdings. Its largest new stake was Kenvue: 1,406,267 shares worth $28.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $566M trimmed.
- DZ Bank's largest Q3 2023 buy was Kenvue: 1,406,267 shares worth $28.2M.
- DZ Bank added most to CRH in Q3 2023, an estimated $1.1B increase.
- DZ Bank's biggest Q3 2023 reduction was Edwards Lifesciences, cutting an estimated $566M.
- DZ Bank fully exited Zimmer Biomet in Q3 2023, selling an estimated $52M.
- DZ Bank's ten largest holdings make up 35% of its $70.4B portfolio in Q3 2023.
- DZ Bank opened 69 new positions and closed 107 in Q3 2023.
- DZ Bank's portfolio value rose 5.8% quarter-over-quarter to $70.4B.
Based on DZ Bank's 13F filing for Q3 2023, filed 14 Nov 2023.